Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the third quarter of 2023.
In this edition, a mistake is just a mistake, “99.99%” isn’t 100% clear, and faxes aren’t always free. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more. This edition’s video features total-loss class actions filed against insurance companies.
We wrap up the Roundup with a summary of class action settlements finalized in the third quarter.
Class Action MDL Roundup
December 18, 2023
Class Action & MDL Roundup 2023 Q3 - Catching the class action waive(r)
- Cari K. Dawson
- David Venderbush
- Ryan P. Ethridge
- Samantha Burdick
- Sean R. Crain
- R. Blake Crohan
- Gillian H. Clow
- Jamie S. George
- Bradley Harder
- Sheena Hilton
- Michelle Jackson
- Madeleine Juszynski Davidson
- Jyoti Jindal Kottamasu
- Kara F. Kennedy
- Laura A. Komarek
- Kate Kostel
- Matthew D. Lawson
- Andrew J. Liebler
- Sarah O’Donohue
- Gavin Reinke
- William J. Repko III
- Noelle Reyes
- Andrew A. Roberts
- Jason Rottner
- Joanna H. Schorr
- Leigh Shapiro
- Oliver M. Sherman
- Troy A. Stram
- Ellie Saathoff
- Andrew T. Sumner
- Nick A. Young
Related News & Insights
-
Class Action MDL Roundup September 29, 2023Class Action & MDL Roundup 2023 Q2 – Ascertainability lives!In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2023, essential oils may need therapy, an ever-growing library goes nowhere, and one exclusion is specifically ambiguous. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup June 30, 2023Class Action & MDL Roundup 2023 Q1 – We don’t discount confidentialityIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2023, in pork we antitrust, paid time off is not pay, and if it’s free, it won’t cost you a TCPA violation. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup March 27, 2023Class Action & MDL Roundup 2022 Q4 – A “healthy” dose of litigationIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the fourth quarter of 2022, class actions gain an international flair, insurers have cures for COVID cases, and a remote presence is still a presence. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup December 20, 2022Class Action & MDL Roundup 2022 Q3 – The very definition of all naturalIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the third quarter of 2022, all dog stairs go to heaven, the Third Circuit resets Article III standing, and challenging damages can be aggregating. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action MDL Roundup October 13, 2022Class Action & MDL Roundup 2022 Q2: Directing physical loss and damageIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2022, fail-safe classes fail, consumers smoke a motion to dismiss, and you can’t bring it if you don’t know whodunit. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Media Contact